Off-Label Morning Sickness Drug Deemed Safe for Fetuses
June 11, 2009
Tags: Business & Management, Medical Research, Press Releases
Off-label morning sickness drug, Metoclopramide, poses no significant risks to the fetus according to a large collaborative study by researchers and physicians at Ben-Gurion University of the Negev, Soroka University Medical Center, Clalit Health Services, and the Division of Pharmacology, Hospital for Sick Children in Toronto. The results were published in the June 11 issue of the prestigious New England Journal of Medicine.